Redfund Capital Corporation (CSE:LOAN)(“Redfund” or the “Company”) provides corporate update plus first quarter client financing rundown.

Redfund Capital is pleased to announce Warren D. Cudney, CEO of Wahupta Ventures Inc. to our advisory team. He is recognized as a leader in corporate start-ups and is a speaker in the field of health and wellness, most recently specializing in the emerging hemp and CBD oil and isolate industry throughout North America and the world. As a top C level strategist in this field, Warren is intimately involved with strategic planning and implementation, as well as acting as a key team player in managing this highly specialized field from genetics to finished product development. He is devoted to industry-leading quality control, ensuring that the team vision and corporate goals are continuously met, and creating an environment that ensures excellence in the industry.


Wahupta has been creating a hemp buzz in the western Canadian prairie fields for almost 2 years. As released by Wahupta on January 11th 2019, in its first year in operation, Wahupta harvested an unparalleled 975 acres of hemp and amassed 2.5 million pounds of hemp biomass. Redfund has been advising Wahupta for the past year.

In our First Quarter, Redfund Capital has extended funds to three cannabis companies. The amounts Redfund has advanced to date under the loan facilities, which are specifically designed to be issued in tranches as the investee company advances and reports on its business plan. They are as follows:

RxMM Health, entered into a USD $500,000 promissory note on October 1, 2018 and were extended a first tranche of CDN $220,740.

Mary’s Wellness Ltd., entered into a CDN $1,000,000 promissory note on October 15, 2018 and were extended a first tranche of CDN $100,000.

Winterlife Inc., entered into a USD $1,000,000 promissory note on November 1, 2018 and were extended a first tranche of CDN $100,080.

“Redfund Capital is in the process of converting portfolio client loans into equity positions and building our global brand. As an incubator, it is our role to help our clients increase their current valuations and grow organically to the next cycle in their lifespan. In prior press releases we indicated the intent of some portfolio companies to go public. Such disclosure indicates only their stated intentions to us, and each is responsible for making their way onto the public exchanges.  We believe Wahupta may be the next breakout leader in the hemp sector, and with their vertical operations and farm to field to consumer vision we are very proud to have them as a client in our portfolio and welcome Warren to our advisory team,” said Meris Kott, CEO.

About Wahupta Ventures Inc.

Wahupta Ventures Inc. is a privately held corporation owned and operated in Canada. Wahupta is headquartered in Canada and the US, with offices located in Winnipeg Manitoba, Burnaby British Columbia, Orange County California and Las Vegas Nevada. Wahupta is focused on the cultivation, production, processing, and extraction of hemp and cannabidiol (CBD), while simultaneously creating key collaboration with sovereign Indigenous communities throughout North America.  It is Wahupta’s core value to work with its partners to develop opportunities in communities that do not currently exist, and honor traditional values to addressing current conditions in their individual communities.

About Redfund Capital

Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company’s development, or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcare-related target companies.

For further information please visit www.redfundcapital.com For more information on Redfund Capital contact Meris Kott CEO 604.484.8989 0r info@redfundcapital.comFurther information about the Company is available on www.SEDAR.com under the Company’s profile.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Click here to connect with Redfund Capital Corporation (CSE:LOAN) for an Investor Presentation. 

Source: globenewswire.ca

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less